Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study

Stefano Piaserico; Paolo Gisondi; Clara De Simone; Elena Marinello; Andrea Conti; Paolo Amerio; Andrea Peserico

doi:10.2340/00015555-2209

Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study

Stefano Piaserico^*
, Paolo Gisondi
, Clara De Simone
, Elena Marinello
, Andrea Conti
, Paolo Amerio
, Andrea Peserico

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

8 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	251-252
Numero di pagine	2
Rivista	Acta Dermato-Venereologica
Volume	96
Numero di pubblicazione	2
DOI	https://doi.org/10.2340/00015555-2209
Stato di pubblicazione	Pubblicato - 2016

All Science Journal Classification (ASJC) codes

Dermatologia

Keywords

2708
Adalimumab
Adult
Aged
Anti-Inflammatory Agents
Dermatologic Agents
Etanercept
Female
Humans
Italy
Male
Middle Aged
Psoriasis
Recurrence
Remission Induction
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha

Accesso al documento

10.2340/00015555-2209

Altri file e collegamenti

Cita questo

@article{a4076be19d644508bac2d7022e36ad99,

title = "Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study",

abstract = "N/A",

keywords = "2708, Adalimumab, Adult, Aged, Anti-Inflammatory Agents, Dermatologic Agents, Etanercept, Female, Humans, Italy, Male, Middle Aged, Psoriasis, Recurrence, Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha, 2708, Adalimumab, Adult, Aged, Anti-Inflammatory Agents, Dermatologic Agents, Etanercept, Female, Humans, Italy, Male, Middle Aged, Psoriasis, Recurrence, Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha",

author = "Stefano Piaserico and Paolo Gisondi and \{De Simone\}, Clara and Elena Marinello and Andrea Conti and Paolo Amerio and Andrea Peserico",

year = "2016",

doi = "10.2340/00015555-2209",

language = "English",

volume = "96",

pages = "251--252",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "2",

}

TY - JOUR

T1 - Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study

AU - Piaserico, Stefano

AU - Gisondi, Paolo

AU - De Simone, Clara

AU - Marinello, Elena

AU - Conti, Andrea

AU - Amerio, Paolo

AU - Peserico, Andrea

PY - 2016

Y1 - 2016

N2 - N/A

AB - N/A

KW - 2708

KW - Adalimumab

KW - Adult

KW - Aged

KW - Anti-Inflammatory Agents

KW - Dermatologic Agents

KW - Etanercept

KW - Female

KW - Humans

KW - Italy

KW - Male

KW - Middle Aged

KW - Psoriasis

KW - Recurrence

KW - Remission Induction

KW - Retrospective Studies

KW - Risk Factors

KW - Time Factors

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - 2708

KW - Adalimumab

KW - Adult

KW - Aged

KW - Anti-Inflammatory Agents

KW - Dermatologic Agents

KW - Etanercept

KW - Female

KW - Humans

KW - Italy

KW - Male

KW - Middle Aged

KW - Psoriasis

KW - Recurrence

KW - Remission Induction

KW - Retrospective Studies

KW - Risk Factors

KW - Time Factors

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

UR - https://publicatt.unicatt.it/handle/10807/96106

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84954484196&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84954484196&origin=inward

U2 - 10.2340/00015555-2209

DO - 10.2340/00015555-2209

M3 - Article

SN - 0001-5555

VL - 96

SP - 251

EP - 252

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 2

ER -

Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo